Thrombotic microangiopathy following CAR T-cell therapy: a case series from the EBMT Complications Working Party

Ítems similars

• ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party
  per: Olaf Penack, et al.
  Publicat: (2023-12-01)
• Thrombotic microangiopathy following CAR T-cell therapy: a case series from the EBMT Complications Working Party
  per: Guillaume Dachy, et al.
  Publicat: (2026-07-01)
• PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
  per: Olaf Penack, et al.
  Publicat: (2024-03-01)
• Understanding the Needs and Lived Experiences of Patients With Graft-Versus-Host Disease: Real-World European Public Social Media Listening Study
  per: Zinaida Perić, et al.
  Publicat: (2023-11-01)
• Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party
  per: Nico Gagelmann, et al.
  Publicat: (2025-06-01)